CDKL5 p.Thr288Arg
c.863C>G · rs267606713 · VCV1879751
ClinGen expert panel — Rett and Angelman-like Disorders VCEP
Likely Pathogenic for CDKL5 disorder. Applied ACMG criteria (verbatim):
PM2_Supporting PS4_Supporting PS2 PP3
Curation rationale (ClinGen, verbatim)
The p.Thr288Arg variant in CDKL5 has been reported as a de novo occurrence (biological parentage confirmed) in an individual with early onset epilepsy (internal database - CeGaT Center for Human Genetics Tuebingen) (PS2). The p.Thr288Arg variant has been observed in at least 1 other individual with features of CDKL5 disorder (internal database - LabCorp (formerly Invitae)) (PS4_Supporting). The p.Thr288Arg variant in CDKL5 is absent from gnomAD v4.1 (PM2_Supporting). Computational prediction analysis tools suggests a deleterious impact; however, this information does not predict clinical significance on its own (PP3). In summary, the p.Thr288Arg variant in CDKL5 is classified as Likely Pathogenic for CDKL5 disorder based on the ACMG/AMP criteria (PS2, PS4_Supporting, PM2_Supporting, PP3). (CDKL5 Specifications v5.0; curation approved on 10/28/2025)
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9849 | likely pathogenic ✓ concordant with ClinVar |
|---|---|---|
| REVEL | 0.647 | pathogenic-leaning |
| SaProt | LLR -12.28 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.6 | GERP 2.2, phastCons 1 |
| Regional constraint | o/e 0.35 | constrained · MANE · 91 kb · p 1.2e-21 · regional, not allelic |
| Overall | ||
| CADD | 24.6 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- CDKL5
- Protein
- p.Thr288Arg
- Coding
- c.863C>G
- MANE Select
- NM_001323289
- dbSNP
- rs267606713
- Type
- single nucleotide variant
- Location
- chrX:18598499 (GRCh38)
- Structure
- AlphaFold pLDDT 53.76 · 3 PDB
- Residue 288
- the protein kinase domain; a UniProt-annotated variant site (in dee2); an α-helix
Similar variants
- CDKL5 p.Thr288Ile Conflicting classifications of pathogenicity ★ ⚠ same residue
- CDKL5 c.146-1G>A Pathogenic ★★★ same condition
- CDKL5 p.Ala157Pro Likely pathogenic ★★★ same condition
- CDKL5 p.Ala157Val Likely pathogenic ★★★ same condition
- CDKL5 p.Ala40Val Pathogenic ★★★ same condition
- CDKL5 p.Arg178Gln Pathogenic ★★★ same condition
- CDKL5 p.Arg717= Likely pathogenic ★★★ same condition
- CDKL5 p.Arg948Ter Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdkl5-p-thr288arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown